Complementary functional analyses of polyclonal EGFR-mutant cell pools showed a dose-dependent enrichment of BRAFV600E and a loss of EGFR inhibitor susceptibility.
[npj Precision Oncology]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Intestinal Cell News Clonal Dynamics of BRAF-Driven Drug Resistance in EGFR-Mutant Lung Cancer
